Dose-response analysis of phenytoin on electrically induced seizures and spontaneous activity of cerebellar purkinje cells in the frog.
The hypothesis that phenytoin exerts its anticonvulsant effect by increasing the spontaneous firing rate of cerebellar Purkinje cells was tested in frogs (Rana pipiens). Time-dose-effect relationships were first established for the anticonvulsant effect of phenytoin in intact frogs. Maximal seizures were induced by corneal electroshock (MES), and phenytoin was injected into the ventral lymph sac. At the time of peak effect (3 h), 20-40 mg/kg phenytoin protected 60-80% of frogs against tonic hindlimb extension (THE). With this functional data base, experiments were then undertaken to test the effect of phenytoin on Purkinje cell firing rates. Phenytoin was injected into the ventral lymph sac 30-45 min prior to anesthesia with tricaine. The cranium was opened, the dura mater overlying the cerebellum was removed, and the frog was then curarized. Single-unit extracellular recordings from Purkinje cells were made with NaCl-filled glass micropipettes 2-6 h after phenytoin injection, the expected time of maximum anticonvulsant effect. Effective anticonvulsant doses (20-40 mg/kg) of phenytoin produced no alteration in the spontaneous firing rates of cerebellar Purkinje cells compared to the rates in solvent-injected controls. Consequently, the hypothesis that the anticonvulsant effect of phenytoin is mediated by an action on Purkinje cell firing rates is not supported by the results of this study.
D000818:Animals; D002531:Cerebellum / Q000187:drug effects* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D005260:Female; D008297:Male; D010672:Phenytoin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D011689:Purkinje Cells / Q000187:drug effects* / Q000502:physiology; D011894:Rana pipiens; D012640:Seizures / Q000188:drug therapy
D010672:Phenytoin